Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.

Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug; 114(1):111-6.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents, Alkylating
Brain Neoplasms
Cognition
Combined Modality Therapy
Dacarbazine
Female
Glioblastoma
Humans
Karnofsky Performance Status
Male
Middle Aged
Neuropsychological Tests
Prospective Studies
Quality of Life
Radiotherapy, Intensity-Modulated

authors with profiles

Douglas E Ney
Denise Marie Damek
Laurie Elizabeth Gaspar
Kevin O Lillehei
Brian D Kavanagh

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium